Black garlic improves heart failure of the patients with coronary heart disease by improving circulating antioxidant levels

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017999

Enrollment

Unknown

Registered

2018-08-25

Start date

2017-02-23

Completion date

Unknown

Last updated

2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

black garlic and placebo groups:black garlic versus placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: At the same time Framingham's heart failure qualitative diagnostic criteria and Boston heart failure quantitative diagnostic criteria; age 35 to 75 years; left ventricular ejection fraction (EF) =50; heart function grades II-III.

Exclusion criteria

Exclusion criteria: The participants would be excluded if they had a history of knee surgery within past 3 months, a systemic arthritic condition, and any other muscular, joint or neurological condition affecting lower limb function. The patients had acute coronary syndrome, severe valvular heart disease, combined shock, planned extracardiac surgery, combined hepatorenal and other systemic diseases.

Design outcomes

Primary

Measure	Time frame
quality of life;	—

Countries

China

Contacts

Public ContactChengfei Wen

The First Hospital of Jilin University

wenchengfei00@126.com+86 15143173560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026